Inspiring story shared by @SafiBahcall on #PatientExperience
Brian Druker was denied tenure because his work was felt to lack 'potential'. Drug he discovered: Gleevec (imatinib).
Life expectancy of pts with chronic myeloid leukemia today: normal.
#JPMHC20 #JPM20
Brian Druker was denied tenure because his work was felt to lack 'potential'. Drug he discovered: Gleevec (imatinib).
Life expectancy of pts with chronic myeloid leukemia today: normal.
#JPMHC20 #JPM20
A few years ago Safi attended a research meeting sponsored by a patient foundation group. One of the first people he met after I in hotel lobby started asking him detailed questions about the science behind the cancer drug they were working on at the time
(he was running a biotech co). After they were done speaking, he asked the other person "What university are you from?"
"I'm not with any university," he said. "I'm a patient. I was diagnosed seven years ago and given 6 months to live.
"I'm not with any university," he said. "I'm a patient. I was diagnosed seven years ago and given 6 months to live.
I was one of the first to get Gleevec. Since then, every day has been a gift. Every sunrise has been more glorious than the one before."
This story is an example of why I love the industry I’m in.
This story is an example of why I love the industry I’m in.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
